HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryuhei Okuyama Selected Research

Ryuhei Okuyama Research Topics

Disease

32Melanoma (Melanoma, Malignant)
11/2022 - 08/2004
18Neoplasms (Cancer)
11/2022 - 08/2004
8Neoplasm Metastasis (Metastasis)
11/2021 - 08/2004
4Psoriasis (Pustulosis Palmaris et Plantaris)
09/2021 - 03/2011
4Psoriatic Arthritis
01/2021 - 10/2016
4Inflammation (Inflammations)
03/2018 - 11/2005
3Infections
09/2020 - 01/2006
3Atopic Dermatitis (Atopic Eczema)
10/2019 - 11/2012
3Mycosis Fungoides
01/2017 - 01/2006
3Wounds and Injuries (Trauma)
07/2015 - 03/2006
2Leg Ulcer
12/2021 - 01/2011
2Hypersensitivity (Allergy)
10/2019 - 01/2017
2Vasculitis (Vasculitides)
02/2018 - 08/2013
2Basal Cell Carcinoma (Rodent Ulcer)
03/2016 - 06/2014
2Pyogenic Granuloma
03/2016 - 09/2010
1Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2022
1Rheumatoid Vasculitis
12/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2021
1Hypohidrosis
04/2021
1Circulating Neoplastic Cells
03/2021
1Brain Neoplasms (Brain Tumor)
03/2021
1Sacroiliitis
01/2021
1Spondylitis
01/2021
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
12/2020
1Extramammary Paget Disease (Paget Disease, Extramammary)
11/2020
1Ankylosing Spondylitis
01/2020
1Dermatitis
10/2019
1Thymoma (Thymic Carcinoma)
06/2019
1Porphyria Cutanea Tarda
01/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2018
1Colonic Neoplasms (Colon Cancer)
01/2018

Drug/Important Bio-Agent (IBA)

9NivolumabIBA
11/2022 - 01/2016
7Biomarkers (Surrogate Marker)IBA
11/2022 - 10/2016
6Proteins (Proteins, Gene)FDA Link
11/2022 - 11/2005
6Immune Checkpoint InhibitorsIBA
03/2021 - 01/2016
5LigandsIBA
11/2022 - 01/2014
5AntibodiesIBA
07/2021 - 01/2016
4DNA (Deoxyribonucleic Acid)IBA
11/2019 - 10/2016
4IpilimumabIBA
11/2019 - 12/2012
4AntigensIBA
02/2018 - 12/2012
3pembrolizumabIBA
11/2022 - 06/2016
3Therapeutic UsesIBA
11/2022 - 11/2005
3Paclitaxel (Taxol)FDA LinkGeneric
11/2020 - 12/2013
3Cell-Free Nucleic AcidsIBA
03/2020 - 01/2016
3InterleukinsIBA
01/2018 - 04/2009
2CytokinesIBA
11/2022 - 07/2015
2Pharmaceutical PreparationsIBA
11/2022 - 03/2021
2SteroidsIBA
01/2022 - 01/2006
2Neoplasm Antigens (Tumor Antigens)IBA
07/2021 - 01/2018
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2021 - 01/2014
2Melanins (Melanin)IBA
02/2021 - 01/2021
2Adalimumab (Humira)FDA Link
01/2021 - 01/2020
2ErbB Receptors (EGF Receptor)IBA
11/2020 - 04/2016
2CysteinyldopaIBA
01/2020 - 11/2018
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
10/2019 - 01/2017
2Nerve Growth Factors (Neurotrophins)IBA
10/2019 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 08/2010
2Immunoglobulin E (IgE)IBA
09/2016 - 11/2005
25-hydroxymethylcytosineIBA
05/2016 - 02/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2016 - 04/2009
2Immunoglobulin G (IgG)IBA
11/2014 - 04/2009
2LipopolysaccharidesIBA
01/2014 - 04/2009
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2010 - 06/2006
2Adenosine Triphosphate (ATP)IBA
05/2010 - 04/2009
2CPG-oligonucleotideIBA
11/2005 - 08/2004
2OligodeoxyribonucleotidesIBA
11/2005 - 08/2004
1Programmed Cell Death 1 ReceptorIBA
11/2022
1ChemokinesIBA
11/2022
1Etanercept (Enbrel)FDA Link
01/2022
1apalutamideIBA
01/2022
1Certolizumab PegolFDA Link
12/2021
1Tissue Inhibitor of Metalloproteinase-3IBA
11/2021
1Cysteine (L-Cysteine)FDA Link
11/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
09/2021
1Angiotensin Receptors (Angiotensin II Receptor)IBA
07/2021
1Carbonic Anhydrase IIIBA
04/2021
1LipidsIBA
03/2021
1Fatty Acid-Binding Protein 7IBA
03/2021
1CateninsIBA
03/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2020
1Trastuzumab (Herceptin)FDA Link
11/2020
1human ERBB2 proteinIBA
11/2020
1Voriconazole (Vfend)FDA LinkGeneric
09/2020
1Type 1 Angiotensin ReceptorIBA
01/2020
1C-Reactive ProteinIBA
01/2020
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2020
1Immunoglobulins (Immunoglobulin)IBA
06/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1Acyclovir (Aciclovir)FDA LinkGeneric
09/2018
1Antimicrobial PeptidesIBA
03/2018
1CathelicidinsIBA
03/2018
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
02/2018
1B7-H1 AntigenIBA
01/2018
1Angiotensin Receptor AntagonistsIBA
01/2018
1ArginaseIBA
01/2018

Therapy/Procedure

26Therapeutics
11/2022 - 08/2004
7Immunotherapy
01/2020 - 11/2005
3Molecular Targeted Therapy
03/2021 - 11/2012
2Combination Drug Therapy (Combination Chemotherapy)
11/2020 - 12/2013
1Transplantation
09/2018